Table 4 Relationship between tumor response, concurrent chemotherapy and patterns of treatment failure (n = 83)
Characteristic | Persistent local disease (%) | Locoregional recurrence (%) | Distant metastasis (%) | Multiple failures (%) |
|---|---|---|---|---|
Tumor response | Â | Â | Â | Â |
CR (n = 37) | 0 (0%) | 6 (16.2%) | 5 (13.5%) | 1 (2.7%) |
Non-CR (n = 46) | 9 (19.6%) | 12 (26.1%) | 13 (28.3%) | 1 (2.2%) |
Concurrent chemotherapy | Â | Â | Â | Â |
PF (n = 39) | 6 (15.4%) | 12 (30.8%) | 9 (23.1%) | 1 (2.6%) |
TP (n = 44) | 3 (6.8%) | 6 (13.6%) | 9 (20.5%) | 1 (2.3%) |
Total (n = 83) | 9 (10.8%) | 18 (21.7%) | 18 (21.7%) | 2 (2.4%) |